JP2005500262A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005500262A5 JP2005500262A5 JP2002581444A JP2002581444A JP2005500262A5 JP 2005500262 A5 JP2005500262 A5 JP 2005500262A5 JP 2002581444 A JP2002581444 A JP 2002581444A JP 2002581444 A JP2002581444 A JP 2002581444A JP 2005500262 A5 JP2005500262 A5 JP 2005500262A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- acid
- carrier
- diluent
- diazabicyclo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0101329A SE0101329D0 (sv) | 2001-04-12 | 2001-04-12 | Pharmaceutical formulation |
| PCT/SE2002/000726 WO2002083689A1 (en) | 2001-04-12 | 2002-04-12 | 3,7-diazabicyclo [3.3.1] formulations as anti-arrythmic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005500262A JP2005500262A (ja) | 2005-01-06 |
| JP2005500262A5 true JP2005500262A5 (https=) | 2005-12-22 |
Family
ID=20283785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002581444A Withdrawn JP2005500262A (ja) | 2001-04-12 | 2002-04-12 | 抗不整脈化合物としての３，７−ジアザビシクロ［３．３．１］製剤 |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US20050037067A1 (https=) |
| EP (1) | EP1389212B1 (https=) |
| JP (1) | JP2005500262A (https=) |
| KR (1) | KR20030088498A (https=) |
| CN (1) | CN1514839A (https=) |
| AR (1) | AR035806A1 (https=) |
| AT (1) | ATE332902T1 (https=) |
| BG (1) | BG108234A (https=) |
| BR (1) | BR0208828A (https=) |
| CA (1) | CA2443473A1 (https=) |
| CZ (1) | CZ20032774A3 (https=) |
| DE (1) | DE60213084T2 (https=) |
| EE (1) | EE200300495A (https=) |
| HU (1) | HUP0303486A3 (https=) |
| IL (1) | IL158033A0 (https=) |
| IS (1) | IS6989A (https=) |
| MX (1) | MXPA03009209A (https=) |
| NO (1) | NO20034529L (https=) |
| NZ (1) | NZ528561A (https=) |
| PL (1) | PL366629A1 (https=) |
| RU (1) | RU2003129230A (https=) |
| SE (1) | SE0101329D0 (https=) |
| SK (1) | SK12562003A3 (https=) |
| TW (1) | TWI257391B (https=) |
| WO (1) | WO2002083689A1 (https=) |
| ZA (1) | ZA200307756B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI259836B (en) * | 2001-04-12 | 2006-08-11 | Astrazeneca Ab | Modified release formulation suitable for antiarrhythmic compounds |
| US8158152B2 (en) * | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| GB0523810D0 (en) * | 2005-11-23 | 2006-01-04 | Astrazeneca Ab | Pharmaceutical compositions |
| EP1968593B1 (en) * | 2005-12-20 | 2017-08-23 | LEK Pharmaceuticals d.d. | Pharmaceutical composition comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl-(3r,5s)-3,5-dihydroxyhept-6-enoic acid |
| US20080085303A1 (en) * | 2006-10-10 | 2008-04-10 | Penwest Pharmaceuticals Co. | Robust sustained release formulations of oxymorphone and methods of use thereof |
| US20090142398A1 (en) * | 2007-11-21 | 2009-06-04 | Pharmascience Inc. | Novel pharmaceutical compositions comprising a disintegration matrix |
| DE102008047910A1 (de) | 2008-09-19 | 2010-03-25 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Tablettierhilfsstoff auf Laktose- und Cellulosebasis |
| WO2014157603A1 (ja) * | 2013-03-29 | 2014-10-02 | アステラス製薬株式会社 | 経口投与用医薬組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3732094A1 (de) * | 1987-09-24 | 1989-04-06 | Basf Ag | Bispidinderivate als klasse iii-antiarrhythmika |
| US5110933A (en) * | 1989-11-13 | 1992-05-05 | Board Of Regents Of Oklahoma State University | Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof |
| DE4402933A1 (de) * | 1994-02-01 | 1995-08-03 | Kali Chemie Pharma Gmbh | Neue 3-Benzoyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel |
| SE9704709D0 (sv) * | 1997-12-17 | 1997-12-17 | Astra Ab | Pharmaceutically active compounds |
| CN1147483C (zh) * | 1999-04-09 | 2004-04-28 | 阿斯特拉曾尼卡有限公司 | 金刚烷衍生物 |
| SE9903759D0 (sv) * | 1999-10-18 | 1999-10-18 | Astra Ab | Pharmaceutically active compounds |
| US6500457B1 (en) * | 2000-08-14 | 2002-12-31 | Peirce Management, Llc | Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent |
-
2001
- 2001-04-12 SE SE0101329A patent/SE0101329D0/xx unknown
-
2002
- 2002-04-01 TW TW091106495A patent/TWI257391B/zh not_active IP Right Cessation
- 2002-04-02 AR ARP020101187A patent/AR035806A1/es not_active Application Discontinuation
- 2002-04-12 JP JP2002581444A patent/JP2005500262A/ja not_active Withdrawn
- 2002-04-12 WO PCT/SE2002/000726 patent/WO2002083689A1/en not_active Ceased
- 2002-04-12 RU RU2003129230/15A patent/RU2003129230A/ru not_active Application Discontinuation
- 2002-04-12 CA CA002443473A patent/CA2443473A1/en not_active Abandoned
- 2002-04-12 US US10/474,584 patent/US20050037067A1/en not_active Abandoned
- 2002-04-12 EE EEP200300495A patent/EE200300495A/xx unknown
- 2002-04-12 AT AT02723011T patent/ATE332902T1/de not_active IP Right Cessation
- 2002-04-12 IL IL15803302A patent/IL158033A0/xx unknown
- 2002-04-12 SK SK1256-2003A patent/SK12562003A3/sk unknown
- 2002-04-12 CZ CZ20032774A patent/CZ20032774A3/cs unknown
- 2002-04-12 HU HU0303486A patent/HUP0303486A3/hu unknown
- 2002-04-12 PL PL02366629A patent/PL366629A1/xx not_active Application Discontinuation
- 2002-04-12 EP EP02723011A patent/EP1389212B1/en not_active Expired - Lifetime
- 2002-04-12 MX MXPA03009209A patent/MXPA03009209A/es not_active Application Discontinuation
- 2002-04-12 KR KR10-2003-7013299A patent/KR20030088498A/ko not_active Withdrawn
- 2002-04-12 DE DE60213084T patent/DE60213084T2/de not_active Expired - Fee Related
- 2002-04-12 CN CNA028116364A patent/CN1514839A/zh active Pending
- 2002-04-12 NZ NZ528561A patent/NZ528561A/en unknown
- 2002-04-12 BR BR0208828-2A patent/BR0208828A/pt not_active IP Right Cessation
-
2003
- 2003-10-03 ZA ZA200307756A patent/ZA200307756B/en unknown
- 2003-10-06 BG BG108234A patent/BG108234A/bg unknown
- 2003-10-09 NO NO20034529A patent/NO20034529L/no not_active Application Discontinuation
- 2003-10-10 IS IS6989A patent/IS6989A/is unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107530348B (zh) | 一种含有jak激酶抑制剂或其可药用盐的药物组合物 | |
| WO2008032107A1 (en) | Solid dosage form of olmesartan medoxomil and amlodipine | |
| CN102196811A (zh) | 含有4,5-环氧基吗啡烷衍生物的稳定片剂 | |
| JP2005500262A5 (https=) | ||
| KR20220097431A (ko) | X842의 경구용 제제 | |
| ZA200409237B (en) | Immediate release pharmaceutical formulation. | |
| WO2012079203A1 (zh) | 一种葛根素水合物、其制备方法及用途 | |
| JP2004510775A5 (https=) | ||
| RU2003129230A (ru) | 3,7-диазабицикло[3.3.1]-препараты как антиаритмические соединения | |
| US6011043A (en) | Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction | |
| NZ538519A (en) | Bicifadine formulation for reducing pain | |
| AU2021235395B2 (en) | Controlled release formulations comprising Drotaverine or salt thereof | |
| KR20150111686A (ko) | 산화안정성이 향상된 텔미사르탄 및 (ｓ)-암로디핀을 포함하는 약제학적 제제 | |
| WO2011093828A2 (en) | Solid dosage forms comprising cefprozil | |
| KR20210152280A (ko) | 몬테루카스트와 레보세티리진을 포함하는 안정성이 향상된 단일 정제 및 이의 제조방법 | |
| JP2016124861A (ja) | オルメサルタンメドキソミル含有口腔内崩壊錠 | |
| EP2809316A1 (en) | Synergisctic combination comprising a meglitinide derivative and lipoic acid | |
| NZ528559A (en) | Oxabispidine compounds in delayed and sustained release pharmaceutical compositions | |
| EP1567131A1 (en) | Bupropion hydrochloride solid dosage forms | |
| WO2019087054A1 (en) | Novel pharmaceutical composition comprising dpp-4 inhibitor, alpha-lipoic acid and vitamin b12 | |
| KR101068476B1 (ko) | 로피니롤 경구 투여용 서방성 제제 | |
| KR20110056071A (ko) | 올란자핀을 함유하는 확산정 조성물 및 이에 의해 형성된 정제 | |
| JPWO2022031666A5 (https=) | ||
| AU2016260785B2 (en) | Clonidine and/or Clonidine derivatives for use in the prevention of skin injury resulting from radiotherapy | |
| TW201625249A (zh) | 醫藥組成物及其用途 |